Honggang Yi

No ORCID on file · 2 papers in corpus
rct 2024
Nature communications ·doi:10.1038/s41467-024-52008-y

In this multicenter, non-inferiority, randomized trial, we randomly assigned 992 women undergoing in-vitro fertilization (IVF) with a good prognosis (aged 20-40, ≥3 transferrable cleavage-stage embryos) to strategies of blastocyst-stage (n …

rct 2019
Annals of translational medicine ·doi:10.21037/atm.2019.04.16

BACKGROUND: This clinical trial aimed to compare the clinical efficacy of highly purified human menopausal gonadotropin (HP-HMG) plus recombinant human follicle-stimulating hormone (rFSH) versus rFSH alone on controlled ovarian stimulation …